Safety and Tolerability of Eptinezumab in Patients With Migraine: A Pooled Analysis of 5 Clinical Trials

被引：0
|
作者：
Smith, Timothy R. [1 ]
Spierings, Egilius L. H. [2 ]
Cady, Roger [3 ]
Hirman, Joe [4 ]
Schaeffler, Barbara [3 ]
Shen, Vivienne [5 ]
Sperling, Bjorn [6 ]
Brevig, Thomas [6 ]
Josiassen, Mette Krog [6 ]
Brunner, Elizabeth [5 ]
Mehta, Lahar [3 ]
机构：
[1] StudyMetrix Res, St Peters, MO USA
[2] Medvadis Res Corp, Boston PainCare, Waltham, MA USA
[3] Lundbeck Seattle BioPharmaceut Inc, Bothell, WA USA
[4] Pacific Northwest Stat Consulting Inc, Woodinville, WA USA
[5] Lundbeck LLC, Deerfield, IL USA
[6] H Lundbeck & Co AS, Copenhagen, Denmark
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1767
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Safety and tolerability of erenumab in older migraine patients: A subgroup analysis of randomised trials
    Lampl, Christian
    Snellman, Josefin
    Ritter, Shannon
    Klatt, Jan
    NEUROLOGY, 2020, 94 (15)
  • [12] Safety and tolerability of erenumab in older migraine patients: A subgroup analysis of randomised trials
    Lampl, Christian
    Snellman, Josefin
    Ritter, Shannon
    Klatt, Jan
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 399 - 400
  • [13] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
    Sven Kohler
    Cordula Zeller
    Hristo Iliev
    Stefan Kaspers
    Advances in Therapy, 2017, 34 : 1707 - 1726
  • [14] Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Diener, Hans Christoph
    McAllister, Peter
    Jurgens, Tim P.
    Kessler, Yoel
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Barash, Steve
    Silberstein, Stephen D.
    CEPHALALGIA, 2022, 42 (08) : 769 - 780
  • [15] Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies
    Vargas, Bert B.
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    McAllister, Peter
    NEUROLOGY, 2020, 94 (15)
  • [16] Safety and Tolerability of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies
    McAllister, Peter
    Ning, Xiaoping
    Kessler, Yoel
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    ANNALS OF NEUROLOGY, 2020, 88 : S158 - S159
  • [17] Safety and Tolerability of Rufinamide in Pediatric Patients: Pooled Data from the Rufinamide Clinical Trials in Epilepsy
    Wheless, J.
    Conry, J.
    Krauss, G.
    Mann, A.
    LoPresti-Solis, A.
    Narurkar, M.
    ANNALS OF NEUROLOGY, 2009, 66 : S126 - S126
  • [18] Safety and tolerability of atogepant: A post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M. J.
    Robblee, J.
    McVige, J. W.
    Sacco, S. E.
    Ferreira, R.
    Rekeda, L.
    Ma, J.
    Dabruzzo, B. L.
    Ashina, M.
    HEADACHE, 2022, 62 : 121 - 122
  • [19] Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M.
    Robblee, J.
    McVige, J.
    Sacco, S.
    Ferreira, R. De Abreu
    Rekeda, L.
    Ma, J.
    Dabruzzo, B.
    Ashina, M.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [20] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials
    Kohler, Sven
    Zeller, Cordula
    Iliev, Hristo
    Kaspers, Stefan
    ADVANCES IN THERAPY, 2017, 34 (07) : 1707 - 1726
12345